Aktiesnakken — August 2012
-
så 50 musd må give 7-8 kurspoint
-
111 lyder da bedre
-
den i 71,6 har ligget der siden 42
-
arzerra salgstal
-
ny duobody deal
-
men dara aftalen kan jo i teorien blive en del større end vi tror
-
kan han få 75 musd hjem kanske?
-
fabrikken giver nok 5-6 point
-
men det er et big IF
-
Og vi er kun lige startet
-
omsætningen er ikke stærk og det er faktisk bullish!
-
for ingen sælger!
-
haha investor 1989, Duobody - Arzerra - Daratumumab http://www.youtube.com/watch?v=FdDrDa9PGJg
-
DAD
-
ding ding
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind